SNPTECH REPORTER SUBSCRIBERS: As Pharmacogenomics Matures In US, European Space Grapples for Traction | GenomeWeb

The pharmacogenomics wave does not seem to have hit European shores just yet: Venture capitalists there have a tepid interest in local SNP and pharmacogenomic startups, and companies there anxious about private-equity financing are in for a long, hot summer, most experts agree. It didn t have to be this way. Subscribe. (https://www.snptech.com/subscribe.htmtarget=_blank)

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.